.RESEARCH STUDY FEATURE.06 August 2024.
A big randomized measured test along with cisgender ladies highlights the challenges of fidelity to a day-to-day oral preexposure prophylaxis regiment and demonstrates that twice-yearly injection of lenacapavir can easily maintain successful HIV prevention degrees over 6 months.